Thioredoxin reductase 1 expression in colon cancer: Discrepancy between in vitro and in vivo findings

Laboratory Investigation

Volumn 83, Issue 9, 2003, Pages 1321-1331

  Lechner, Sandra ^a   Müller Ladner, Ulf ^a   Neumann, Elena ^a   Spöttl, Tanja ^a   Schlottmann, Klaus ^a   Rüschoff, Josef ^b   Schölmerich, Jürgen ^a   Kullmann, Frank ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b KLINIKUM KASSEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; MESSENGER RNA; THIOREDOXIN; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HT29; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTESTINE CRYPT; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; SPHEROID CELL;

ANIMALS; COLON; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; INTESTINAL MUCOSA; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; THIOREDOXIN REDUCTASE (NADPH); TUMOR CELLS, CULTURED;

EID: 0141676724     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000085189.47968.F8     Document Type: Article

References (43)

1. Abate C, Patel L, Rauscher FJ, and Curran T (1990). Redox regulation of fos and jun DNA-binding activity in vitro. Science 249:1157-1161.
2. Baker A, Payne CM, Briehl MM, and Powis G (1997). Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res 57:5162-5167.
3. Bannister AJ, Cook A, and Kouzarides T (1991). In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene 6:1243-1250.
4. Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, and Powis G (1996). Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 16:3459-3466.
5. Berggren M, Gallegos A, Gasdaska J, and Powis G (1997). Cellular thioredoxin reductase activity is regulated by selenium. Anticancer Res 17:3377-3380.
6. Chin YE, Kitagawa M, Kuida K, Flavell RA, and Fu XY (1997). Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 17:5328-5337.
7. Chin YE, Kitagawa M, Su WC, You ZH, Iwamoto Y, and Fu XY (1996). Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272:719-722.
8. Cromlish JA and Roeder RG (1989). Human transcription factor IIIC (TFIIIC). Purification, polypeptide structure, and the involvement of thiol groups in specific DNA binding. J Biol Chem 264:18100-18109.
9. Deiss LP and Kimchi A (1991). A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science 252:117-120.
10. Duhe RJ, Evans GA, Erwin RA, Kirken RA, Cox GW, and Farrar WL (1998). Nitric oxide and thiol redox regulation of Janus kinase activity. Proc Natl Acad Sci USA 95:126-131.
11. Freemerman AJ, Gallegos A, and Powis G (1999). Nuclear factor kappaB transactivation is increased but is not involved in the proliferative effects of thioredoxin overexpression in MCF-7 breast cancer cells. Cancer Res 59:4090-4094.
12. Gallegos A, Berggren M, Gasdaska JR, and Powis G (1997). Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res 57:4965-4970.
13. Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM, and Powis G (1996). Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res 56:5765-5770.
14. Gasdaska JR, Berggren M, and Powis G (1995a). Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell Growth Differ 6:1643-1650.
15. Gasdaska JR, Gasdaska PY, Gallegos A, and Powis G (1996). Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissue. Genomics 37:257-259.
16. Gasdaska JR, Harney JW, Gasdaska PY, Powis G, and Berry MJ (1999a). Regulation of human thioredoxin reductase expression and activity by 3′-untranslated region selenocysteine insertion sequence and mRNA instability elements. J Biol Chem 274:25379-25385.
17. Gasdaska PY, Berggren MM, Berry MJ, and Powis G (1999b). Cloning, sequencing and functional expression of a novel human thioredoxin reductase. FEBS Lett 442:105-111.
18. Gasdaska PY, Gasdaska JR, Cochran S, and Powis G (1995b). Cloning and sequencing of a human thioredoxin reductase. FEBS Lett 373:5-9.
19. Grippo JF, Holmgren A, and Pratt WB (1985). Proof that the endogenous, heat-stable glucocorticoid receptor-activating factor is thioredoxin. J Biol Chem 260:93-97.
20. Hadley KB and Sunde RA (2001). Selenium regulation of thioredoxin reductase and mRNA levels in rat liver. J Nutr Biochem 12:693-702.
21. Hara S, Shoji Y, Sakurai A, Yuasa K, Himeno S, and Imura N (2001). Effects of selenium deficiency on expression of selenoproteins in bovine arterial endothelial cells. Biol Pharm Bull 24:754-759.
22. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, and Yodoi J (1999). Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 274:27891-27897.
23. Hofmann ER, Boyanapalli M, Lindner DJ, Weihua X, Hassel BA, Jagus R, Gutierrez PL, Kalvakolanu DV, and Hofman ER (1998). Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid. Mol Cell Biol 18:6493-6504.
24. Hu J, Ma X, Lindner DJ, Karra S, Hofmann ER, Reddy SP, and Kalvakolanu DV (2001). Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the interferon-retinoid combination. Oncogene 20:4235-4248.
25. Karimpour S, Lou J, Lin LL, Rene LM, Lagunas L, Ma X, Karra S, Bradbury CM, Markovina S, Goswami PC, Spitz DR, Hirota K, Kalvakolanu DV, Yodoi J, and Gius D (2002). Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene 21:6317-6327.
26. Kim MR, Chang HS, Kim BH, Kim S, Baek SH, Kim JH, Lee SR, and Kim JR (2003). Involvements of mitochondrial thioredoxin reductase (TrxR2) in cell proliferation. Biochem Biophys Res Commun 304:119-124.
27. Kullmann F, Judex M, Ballhorn W, Justen HP, Wessinghage D, Welsh J, Yen TJ, Lang B, Hittle JC, McClelland M, Gay S, Scholmerich J, and Muller-Ladner U (1999). Kinesin-like protein CENP-E is upregulated in rheumatoid synovial fibroblasts. Arthritis Res 1:71-80.
28. Laurent TC, Moore EC, and Reichard P (1964). Enzymatic synthesis of deoxyribonucleotides. V: Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli. B J Biol Chem 239:3436-3444.
29. Lechner S, Müller-Ladner U, Neumann E, Dietmaier W, Welsh J, Schölmerich J, Rüschoff J, and Kullmann F (2001). Use of simplified transcriptors for the analysis of gene expression profiles in laser micro-dissected cell populations. Lab Invest 81:1233-1242.
30. Merwin JR, Mustacich DJ, Muller EG, Pearson GD, and Merrill GF (2002). Reporter gene transactivation by human p53 is inhibited in thioredoxin reductase null yeast by a mechanism associated with thioredoxin oxidation and independent of changes in the redox state of glutathione. Carcinogenesis 23:1609-1615.
31. Miller S, Walker SW, Arthur JR, Lewin MH, Pickard K, Nicol F, Howie AF, and Beckett GJ (2002). Selenoprotein expression in endothelial cells from different human vasculature and species. Biochim Biophys Acta 1588:85-93.
32. Miranda-Vizuete A, Damdimopoulos AE, Pedrajas JR, Gustafsson JA, and Spyrou G (1999). Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization. Eur J Biochem 261:405-412.
33. Mustacich D and Powis G (2000). Thioredoxin reductase. Biochem J 346:1-8.
34. Oblong JE, Berggren M, Gasdaska PY, and Powis G (1994). Site-directed mutagenesis of active site cysteines in human thioredoxin produces competitive inhibitors of human thioredoxin reductase and elimination of mitogenic properties of thioredoxin. J Biol Chem 269:11714-11720.
35. Powis G, Briehl M, and Oblong J (1995). Redox signalling and the control of cell growth and death. Pharmacol Ther 68:149-173.
36. Rubartelli A, Bonifaci N, and Sitia R (1995). High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res 55:675-680.
37. Sandalova T, Zhong L, Lindqvist Y, Holmgren A, and Schneider G (2001). Three-dimensional structure of a mammalian thioredoxin reductase: Implications for mechanism and evolution of a selenocysteine-dependent enzyme. Proc Natl Acad Sci USA 98:9533-9538.
38. Schallreuter KU, Janner M, Mensing H, Breitbart EW, Berger J, and Wood JM (1991). Thioredoxin reductase activity at the surface of human primary cutaneous melanomas and their surrounding skin. Int J Cancer 48:15-19.
39. Spyrou G, Enmark E, Miranda-Vizuete A, and Gustafsson J (1997). Cloning and expression of a novel mammalian thioredoxin. J Biol Chem 272:2936-2941.
40. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, et al (1989). ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8:757-764.
41. Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, Yodoi J, and Tursz T (1990). Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci USA 87:8282-8286.
42. Wu Q, Huang K, and Xu H (2003). Effects of long-term selenium deficiency on glutathione peroxidase and thioredoxin reductase activities and expressions in rat aorta. J Inorg Biochem 94:301-306.
43. Yodoi J and Tursz T (1991). ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: Involvement in lymphocyte immortalization by HTLV-I and EBV. Adv Cancer Res 57:381-411.